South Africa has begun rolling out a new HIV prevention injection administered just twice a year, marking a significant step in the country's efforts to curb one of the world's largest HIV epidemics. The treatment offers a promising alternative to daily oral medication, but its impact may be limited by a shortage of available doses and cuts to U.S. foreign aid funding. Health officials warn that without sustained financial support, the reach of the programme could fall far short of its potential.